Results

Total Results: 1,474 records

Showing results for "indicated".

181. Transparency of Reporting Requirements: Effectiveness of Treatments Options for the Prevention of Complications and Treatment of Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research-protocol.pdf
     September 01, 2016 - Source: www.effectivehealthcare.ahrq.gov Published online: September 1, 2016 8 als.gov, indicated

182. A Framework for Assessing Quality Indicators for Cancer Care at the End-of-Life | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cancer-quality-indicator-framework/research

183. A Framework for Assessing Quality Indicators for Cancer Care at the End-of-Life | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cancer-end-of-life-measures-framework/research

184. Introduction to N-of-1 Trials: Indications and Barriers (Chapter 1) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/n-1-trials/research-2014-4

185. Urinary-Incontinence-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_executive.pdf
     April 01, 2012 - Ratios of 1 indicated that the tests likely do not provide accurate UI diagnosis. … Individual RCTs indicated greater continence and improvement in UI with vaginal estrogen formulations … Individual RCTs indicated no difference in adverse effects and treatment discontinuation with active … Studies indicated no consistently greater benefits for continence or improvement of UI with continence … Indirect comparison indicated the comparable effectiveness of nonpharmacological treatments on continence

186. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0004_03-11-2008.pdf
     January 01, 2008 - Effective Health Care Topic Numbers: 0060 Document Completion Date: 1-12-10 1 Results of Topic Selection Process & Next Steps  Noninvasive positive pressure ventilation (NPPV) for acute respiratory failure will go forward for refinement as a systematic review. The scope of this topic, includ…

187. DEcIDE 33: Summary Variables in Observational Resesarch: Propensity Scores and Disease Risk Scores (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
     May 01, 2012 - For example, the indications for use of rosuvastatin in the label are as follows: CRESTOR is indicated

188. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/disparities-quality-improvement_research-protocol.pdf
     February 23, 2012 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: February 23, 2012 1 Evidence-based Practice Center Systematic Review Protocol Project Title: Closing the Quality Gap 2010: Quality Improvement Interventions to Address Health Disparities …

189. Cannabis-2023-Update-Surv-Rep-3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-update-surv-rep-3.pdf
     January 01, 2023 - 1 Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update – Surveillance Report 3 Search Results: March 2024 Systematic Review: Chou R, Ahmed AY, Bougatsos C, Morasco BJ, Gilbreath T, Dana T, Fu R. Living Systematic Review on Cannabis and Other Plant-Based T…

190. Disposition of Comments CER 194 Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-disposition-comments-inhaled-corticosteroids.pdf
     March 19, 2018 - therapeutic options (“Table 1: Included pharmacologic classes and representative drug moieties” as indicated … subset is that the baseline dosing for BUD/Form was 80mcg/4.5mcg daily at night a dose that is not indicated … the only thing that can be concluded from this study is that once daily dosing of a drug that is indicated … This should be indicated more clearly, and if CI, a comma rather than “to” should be used (e.g., (0.46

191. Recombinant-Factor-Viia Clinician (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
     October 01, 2010 - In-Hospital, Off-Label Uses for rFVIIa1 Evidence on Benefits vs. Usual Care Evidence on Harms vs. Usual Care Spontaneous intracranial hemorrhage* No effect on mortality or functional status. ��� Attenuation of hematoma expansion. ��� Increased risk for arterial thromboembolic events, particularly at doses >40 …

192. Disposition of Comments for CER 195 Management of Uterine Fibroids (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-195-disposition-comments-uterine-fibroids.pdf
     December 14, 2017 - The trial, as indicated, did not report on change in fibroid characteristics. … approved medication by FDA for uterine fibroids is leuprolide, which concomitantly with iron therapy is indicated … As noted, total studies with data at the related dose/time interval is indicated in the column headers … The available literature has substantial gaps in collecting this information as indicated by the number … UAE studies are cleary indicated and discussed as a unit.

193. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - We present two summaries on three topics (indicated by an asterisk) that emerged as higher impact potential … United States in April 2012. 14 According to the agent’s prescribing information, florbetapir is indicated … National Institute on Aging, currently available pharmacotherapies indicated for use in patients with

194. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - We present summaries on two topics (indicated below by an asterisk) that emerged as having high-impact … The system is available in Europe, and one report indicated that hospitals there pay about $60,000 … One report (CNN, April 2013) indicated that hospitals in Europe pay about $60,000 for each machine.33

195. S16 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s16.pdf
     October 01, 2007 - fold higher in the community than in the ACAS trial.29 Similar audits of state-by-state performance indicated

196. REQUEST FOR TASK ORDER (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
     April 01, 2010 - REQUEST FOR TASK ORDER The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of AHRQ's Effective Health Care Program. It is a collaborative network of research centers that support the rapid development of new scientific information and analytic tools. The DEcIDE network…

197. Disposition of Comments Technical Brief 30 Assessment Tools for Palliative Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/palliative-care-tools-disposition.pdf
     May 04, 2017 - administered “always felt rushed” in that they did not have time to reflect on the questions and often just indicated … administered “always felt rushed” in that they did not have time to reflect on the questions and often just indicated

198. Disposition of Comments Technical Brief 30 Assessment Tools for Palliative Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/palliative-care-tools-disposition.pdf
     May 04, 2017 - administered “always felt rushed” in that they did not have time to reflect on the questions and often just indicated … administered “always felt rushed” in that they did not have time to reflect on the questions and often just indicated

199. S143 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
     October 01, 2007 - among them is the indication for the drug—a patient must have the condition for which the drug is indicated

200. Disposition of Comments Report for Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_disposition-comments.pdf
     January 27, 2014 - In Table 4 of the evidence report, we indicated that the comparisons of interest included studies that … As indicated in the Search Strategy section of the Methods chapter, we also searched for studies in … As indicated in the response to the previous comment, we searched for studies in clinicaltrials.gov … , several small end user product acceptance trial sites in hospitals have provided feedback and indicated … Results Under the statement of the benefit of cadexomer iodine containing dressings the research indicated